Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
November 10, 2022
Laboratories are a fundamental component of health systems, critical in routine and emergency contexts for both disease surveillance and health services for communicable and non-communicable diseases. Investing in laboratories helps countries to create integrated and resilient health systems, achiev...
Blog Post
October 31, 2022
Many premature deaths from non-communicable diseases can be prevented if countries enact forceful measures to reduce the risk of their citizens falling prey to these diseases. Making it more expensive to consume tobacco, health-harming alcohol, and sugar-sweetened beverages is key to governments ach...
Blog Post
October 06, 2022
Despite alleged “lessons learned” from the COVID-19 pandemic about the need for early containment, getting the messaging right, and a swift rollout of diagnostics, vaccines, and therapeutics, we have seen the same blunders yet again in the monkeypox response, highlighting the inequities in the syste...
Blog Post
October 04, 2022
Most R&D money flows from the private sector, which aims to maximize returns on investment. As a result, health R&D largely skews towards rich countries’ priorities and health system technical capacities, leaving significant gaps in diseases that primarily affect poor and marginalized populations.